Entrepreneur Shane Yeend is backing
a medicinal cannabis company and wants a Donald Trump - style shake - up in SA to fire up a stale bureaucracy.
Constellation Brands moves into cannabis with US$ 191m Canopy Growth Corp stake purchase Constellation Brands has agreed to purchase a near - 10 % stake in Canada - based
medicinal cannabis company Canopy
Constellation Brands moves into cannabis with US$ 191m Canopy Growth Corp stake purchase Constellation Brands has agreed to purchase a near - 10 % stake in Canada - based
medicinal cannabis company Canopy... read more
Major Cannabis Player Sees Florida Sales Surge Over 250 % and Will Acquire 75 % Ownership in Massachusetts Deal Source: Streetwise Reports (4/17/18) A
medicinal cannabis company has seen its Florida sales increase 253 %, and the company just gained 75 % control over a Massachusetts - based dispensary operation, expanding its influence in the medicinal marijuana industry.
Not exact matches
Murdoch University has partnered with a Perth
company which plans to use
cannabis as a
medicinal product, a day after scientists from the University of Western Australia said
cannabis use could damage a person's DNA.
Carella founded the San Francisco - based
company when
cannabis was first legalized for
medicinal use in the city and dispensaries needed more choices of edibles.
Compassion has driven a push to legalise the
medicinal use of
cannabis but debate is raging about whether big pharmaceutical
companies, small start - ups or backyard growers will win the lucrative right to supply what could be a big market.
«It really exemplifies the fact that 80 percent of the public support
medicinal cannabis and even a majority of people support a recreational law,» said Kyle Kingsley, the CEO of Vireo Health, whose
company is one of five that operate in the state's medical marijuana program, in an interview on Capital Tonight.
They have a link to this press release of July 18 so it's a brand new change: «Courtagen Life Sciences Inc. announced today that the
company will be shifting the core focus of its business to
medicinal cannabis genetics and testing.
As the
company reorients its business to respond to the growing opportunities in the
medicinal cannabis industry, the
company has made the decision to wind down its diagnostic neurology testing division.»